REVB logo

Revelation Biosciences, Inc. (REVB)

Profile

Full Name

Revelation Biosciences, Inc.

Ticker

NASDAQ: REVB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 17, 2020

Indexes

Not included

Website

https://www.revbiosciences.com

Employees

8

Key Details

Price

$1.58(+1.28%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$263.04(-49520.83% YoY)

PE ratio

-

Next earnings date

Nov 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.58
    REVB price is $1.58

    30-Day Relative Volume

    0.73
    REVB 30-day relative volume is 0.73

    Price Performance

    Price Most recent change

    +1.28%
    REVB price was up +1.28% on Sep 16, 2025

    Price YTD change

    -92.86%
    REVB price is down -92.86% since January 1st

    Price 1-year change

    -96.36%
    REVB price is down -96.36% year-on-year

    Price 3-year change

    -99.99%
    REVB price is down -99.99% over the past 3 years

    Price Range

    Price All-time high

    $569.02K
    REVB price is currently -100.00% below its historical high of $569.02 thousand

    Price 3-year low

    $1.50
    REVB price is currently +5.33% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.69M
    REVB market capitalization is $2.69 million

    Market cap 3-year change

    -71.96%
    REVB market capitalization is down -71.96% over the past 3 years

    Market cap All-time high

    $139.86M
    REVB market capitalization is currently -98.08% below its historical high of $139.86 million

    Market cap sector rank

    6.12%
    REVB market capitalization is higher than 6.12% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2070.63%
    REVB shares outstanding is up +2070.63% year-on-year

    Shares Outstanding 3-Year Change

    +339820%
    REVB shares outstanding is up +339820% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.10
    REVB beta is -0.10

    200-day SMA

    $9.55
    REVB price is currently -83.46% below its 200-day simple moving average

    50-day SMA

    $2.62
    REVB price is currently -39.65% below its 50-day simple moving average

    RSI

    26.43
    REVB 14-day relative strength index is 26.43

    Volume

    0.73
    REVB 30-day relative volume is 0.73

    ATR

    $0.27
    REVB average true range is $0.27

    10-day Historical Volatility

    155.32%
    REVB 10-day historical volatility is 155.32%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    REVB annual revenue is $0.00

    Revenue Analysts estimate

    -
    REVB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    REVB annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    REVB annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$263.04
    REVB annual earnings per share is -$263.04

    EPS Analysts estimate

    -$12.12
    REVB annual earnings per share is currently +2070.30% higher than the consensus analysts' forecast

    EPS 1-year change

    -49520.83%
    REVB annual earnings per share is down -49520.83% year-on-year

    EPS Sector rank

    2.18%
    REVB annual earnings per share is higher than 2.18% of companies in Healthcare sector

    Profit

    Gross profit

    -$27.90K
    REVB annual gross profit is -$27.90 thousand

    Gross margin

    -
    REVB annual gross profit margin value is unknown

    Operating profit

    -$7.98M
    REVB annual operating income is -$7.98 million

    Operating margin

    -
    REVB annual operating profit margin value is unknown

    Net income

    -$15.04M
    REVB annual net profit is -$15.04 million

    Net margin

    -
    REVB annual net profit margin value is unknown

    Expenses

    Total expenses

    $15.04M
    REVB annual total expenses is $15.04 million

    Operating expenses

    $7.95M
    REVB annual total operating expenses is $7.95 million

    Cost of goods sold

    $27.90K
    REVB annual cost of goods sold is $27.90 thousand

    Selling, general & administrative expenses

    $0.00
    REVB annual SGA is $0.00

    Depreciation and amortization

    $27.90K
    REVB annual depreciation & amortization is $27.90 thousand

    Interest expense

    $0.00
    REVB annual interest expense is $0.00

    Income tax

    $0.00
    REVB annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$7.98M
    REVB annual earnings before interest & taxes is -$7.98 million

    EBITDA

    -$7.95M
    REVB annual EBITDA is -$7.95 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $6.62M
    REVB annual total assets is $6.62 million

    Non current assets

    $56.30K
    REVB annual long term assets is $56.30 thousand

    Current assets

    $6.57M
    REVB annual total current assets is $6.57 million

    Cash and cash equivalents

    $6.50M
    REVB annual cash & cash equivalents is $6.50 million

    Accounts receivable

    -
    REVB annual accounts receivable value is unknown

    Inventory

    $0.00
    REVB annual inventory is $0.00

    Liabilities

    Total liabilities

    $1.91M
    REVB annual total liabilities is $1.91 million

    Long term liabilities

    $0.00
    REVB annual total long term liabilities is $0.00

    Current liabilities

    $1.91M
    REVB annual total current liabilities is $1.91 million

    Accounts payable

    $783.60K
    REVB annual accounts payable is $783.60 thousand

    Debt

    Total debt

    $0.00
    REVB annual total debt is $0.00

    Total debt 1-year change

    0%
    REVB annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    REVB annual long term debt is $0.00

    Short term debt

    $0.00
    REVB annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $4.71M
    REVB annual stockholders equity is $4.71 million

    Book value

    $14.13M
    REVB annual book value is $14.13 million

    Retained earnings

    -$40.51M
    REVB annual retained earnings is -$40.51 million

    Working capital

    $4.65M
    REVB annual working capital is $4.65 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$18.32M
    REVB annual cash flow from operations is -$18.32 million

    Cash from operations 1-year change

    -151.45%
    REVB annual cash flow from operations is down -151.45% year-on-year

    Cash from investing

    -$19.20K
    REVB annual cash flow from investing activities is -$19.20 thousand

    Cash from investing 1-year change

    -100%
    REVB annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $12.85M
    REVB annual cash flow from financing activities is $12.85 million

    Cash from financing 1-year change

    -8.39%
    REVB annual cash flow from financing activities is down -8.39% year-on-year

    CAPEX

    CAPEX

    $19.20K
    REVB annual capital expenditures is $19.20 thousand

    CAPEX 1-year change

    +100%
    REVB annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free cash flow

    -$18.34M
    REVB annual free cash flow is -$18.34 million

    Free cash flow 1-year change

    -151.71%
    REVB annual free cash flow is down -151.71% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    REVB annual gross profit margin value is unknown

    Operating margin

    -
    REVB annual operating profit margin value is unknown

    Net margin

    -
    REVB annual net profit margin value is unknown

    ROA & ROE

    ROA

    -159.69%
    REVB annual return on assets is -159.69%

    ROE

    -264.85%
    REVB annual return on equity is -264.85%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    REVB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    REVB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.70
    REVB price to book ratio is 0.70

    PB ratio Sector rank

    28.85%
    REVB price to book ratio is higher than 28.85% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    REVB price to sales ratio value is unknown

    PS ratio Sector rank

    -
    REVB price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$2.49M
    REVB enterprise value is -$2.49 million

    Enterprise value Sector rank

    8.21%
    REVB enterprise value is higher than 8.21% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.31
    REVB EV/EBITDA is 0.31

    EV/EBITDA Sector rank

    70.04%
    REVB EV/EBITDA is higher than 70.04% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.43
    REVB annual current ratio is 3.43

    Quick ratio

    3.43
    REVB annual quick ratio is 3.43

    Leverage

    Debt to equity

    0.00
    REVB annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    REVB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    REVB piotroski f-score value is unknown

    Altman Z-Score

    -10.85
    REVB altman z-score is -10.85

    Analyst ratings

    Recent major analysts updates

    Feb 14, 23 Roth MKM
    Buy
    Feb 17, 22 Roth Capital
    Buy

    Institutional Ownership

    Screeners with REVB included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Revelation Biosciences, Inc.?
    • Does Revelation Biosciences, Inc. pay dividends?
    • What sector is Revelation Biosciences, Inc. in?
    • What industry is Revelation Biosciences, Inc. in?
    • What country is Revelation Biosciences, Inc. based in?
    • When did Revelation Biosciences, Inc. go public?
    • Is Revelation Biosciences, Inc. in the S&P 500?
    • Is Revelation Biosciences, Inc. in the NASDAQ 100?
    • Is Revelation Biosciences, Inc. in the Dow Jones?
    • When was Revelation Biosciences, Inc.'s last earnings report?
    • When does Revelation Biosciences, Inc. report earnings?

    What is the ticker symbol for Revelation Biosciences, Inc.?

    The ticker symbol for Revelation Biosciences, Inc. is NASDAQ:REVB

    Does Revelation Biosciences, Inc. pay dividends?

    No, Revelation Biosciences, Inc. does not pay dividends

    What sector is Revelation Biosciences, Inc. in?

    Revelation Biosciences, Inc. is in the Healthcare sector

    What industry is Revelation Biosciences, Inc. in?

    Revelation Biosciences, Inc. is in the Biotechnology industry

    What country is Revelation Biosciences, Inc. based in?

    Revelation Biosciences, Inc. is headquartered in United States

    When did Revelation Biosciences, Inc. go public?

    Revelation Biosciences, Inc.'s initial public offering (IPO) was on November 17, 2020

    Is Revelation Biosciences, Inc. in the S&P 500?

    No, Revelation Biosciences, Inc. is not included in the S&P 500 index

    Is Revelation Biosciences, Inc. in the NASDAQ 100?

    No, Revelation Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Revelation Biosciences, Inc. in the Dow Jones?

    No, Revelation Biosciences, Inc. is not included in the Dow Jones index

    When was Revelation Biosciences, Inc.'s last earnings report?

    Revelation Biosciences, Inc.'s most recent earnings report was on August 8, 2025

    When does Revelation Biosciences, Inc. report earnings?

    The next expected earnings date for Revelation Biosciences, Inc. is November 7, 2025
    On this page